A Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast Milk

Clinical trial NCT06143514 · RECRUITING

Trial details

NCT number: NCT06143514
Sponsor: TG Therapeutics, Inc.
Status: RECRUITING
Study type: OBSERVATIONAL

Relapsing Multiple Sclerosis

Start date: 2024-03-26
Primary completion: 2026-10-31
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.